Neurology

Behavioral Neurology & Neuropsychiatry

Questions discussed in this category

How do you treat extrapyramidal symptoms secondary to anti-psychotic use in patients who have not benefited from cogentin or benadryl?

1 Answer available

When do you select cholinesterase inhibitors vs NMDA-antagonist medications in patients with moderate Alzheimer’s dementia?

1 Answer available

How does APOE4 status affect your clinical decision-making in patients who may be eligible for anti-amyloid therapies for early Alzheimer's disease?

Does APOE4 status have any impact on how you would choose between lecanemab vs donanemab?

5 Answers available

When do you consider using stimulants in patients with cognitive impairments secondary to traumatic brain injury?

1 Answer available

What medications do you prioritize or avoid in Parkinson’s Disease-related psychosis and behavioral disturbance?

2 Answers available

How do you counsel elderly patients who demonstrate mild cognitive impairment but do not meet the criteria for a neurocognitive disorder?

1 Answer available

What are preferred sleep aids in elderly patients with dementia?

6 Answers available

Do you ever use amantadine or modafinil to aid in the rehabilitation of patients with ischemic strokes?

In patients who have decreased arousal after ischemic stroke, do you use amantadine or modafinil to aid with wakefulness and interaction with therapy ...

1 Answer available

How do you counsel eligible patients on how to decide between lecanemab vs donanemab?

3 Answers available

What is the minimum level of cognitive symptoms that would prompt you to pursue biomarker testing required for anti-amyloid therapies for Alzheimer's?

4 Answers available

Is a history of coronary artery disease and afib a contraindication to using donepezil?

How do you counsel patients about any potential risk?

1 Answer available

What would prompt discontinuing treatment versus switching or sequencing treatment in patients treated with an anti-amyloid therapy for Alzheimer's?

3 Answers available

What is your approach to patients who develop ARIA-E or ARIA-H during treatment with anti-amyloid therapies?

2 Answers available

Do you use amyloid lowering therapy in patients on chronic anticoagulation?

How do you counsel them on the risk?

1 Answer available

Is the p-tau217 plasma test used as a surrogate for amyloid PET scan or CSF testing when considering starting Leqembi in patients with Alzheimer's disease?

1 Answer available

What are the best practices for centers interested in providing anti-amyloid therapies for early Alzheimer's to ensure treatment delivery success?

2 Answers available

Do you recommend thiamine for patients presenting with acute symptoms of TGA?

1 Answer available

How do you approach the psychiatric symptom management of Huntington’s Disease?

1 Answer available

What is your approach to addressing dementia-related agitation for patients living at home with family?

1 Answer available

How do you manage stroke-related abulia?

1 Answer available

Do you get volumetric MRI in all patients with cognitive difficulties?

1 Answer available

Would you avoid the use of keppra in patients with TBI due to concerns for worsening agitation?

2 Answers available

How will your approach to screening and diagnosis of early dementia change given newly available therapies for early Alzheimer's disease?

5 Answers available

What are the recommendations for considering deep brain stimulation in a patient with tremors and dementia or mild cognitive impairment?

Does the approach differ if the tremor stems from essential tremor or Parkinson's disease?

1 Answer available

Would you consider AEDs in patients with recurrent TGA?

1 Answer available

How would you manage cognitive changes in a patient with memory impairment and significant brain atrophy with no diagnostic testing consistent with Alzheimer's disease?

1 Answer available

How do you approach patients with recurrent TGA in the emergency room?

1 Answer available

Do you typically obtain an EEG in patients undergoing workup for cognitive dysfunction?

5 Answers available

What lifestyle choices are helpful in reducing the risk of or slowing cognitive decline?

2 Answers available

In what clinical situation would you consider using benzodiazepines in patients with dementia?

2 Answers available

When do you recommend neuropsychiatric testing in patients with post-concussive syndrome?

4 Answers available

How do you explain the clinical benefit of lecanemab or donanemab to patients?

Do you feel the study outcomes are clinically meaningful?

3 Answers available

Is there a point at which further reduction in amyloid burden is no longer clinically meaningful or should the goal always be as much reduction as possible?

4 Answers available

How long after a motor vehicle accident would you expect symptoms including memory loss, hypersomnia, and mood changes to be attributable to the accident?

Traumatic brain injury

1 Answer available

How will you counsel patients regarding ARIA?

Do you see utility in trending serum neurofilament light chain levels or any alternative screening methods beyond MRI to help identify amyloid-related...

2 Answers available

What makes a patient a good candidate for treatments targeting amyloid such as lecanemab or donanemab?

Are there patients in whom you would specifically avoid this class of treatments?

2 Answers available

What work-up do you recommend in patients with early-onset dementia?

Which genetic/other testing should be considered in an early-onset dementia work-up?

1 Answer available

Is it possible to develop worsening motor features of Parkinson's disease (PD) when using clozapine (for treatment of PD psychosis) above a certain dose?

If so, what is the recommended maximum dose of clozapine for PD patients?

1 Answer available

When do you recommend lumbar puncture in patients with concern for memory loss?

1 Answer available

Do you check neurofilament light chain in patients with neurodegenerative illnesses?

1 Answer available

Do you use acetylcholinesterase inhibitors in patients with cognitive changes in the setting of cerebral amyloid angiopathy?

1 Answer available

How would you manage a patient with secondary progressive multiple sclerosis manifesting with increased neuropsychiatric manifestations (ex. psychosis) with no recent changes on brain MRI?

1 Answer available

When do you consider prescribing medications such as Aricept in patients with Down Syndrome who start having memory issues?

2 Answers available

When do you recommend driving tests in patients who have memory loss?

1 Answer available

How do you manage the developmental and behavioral regression seen in Down Syndrome Disintegrative Disorder (DSDD)?

1 Answer available

How do you treat behavioral disturbances in patients with dementia with Lewy bodies?

How do you treat dangerous behavioral disturbances (aggression, nighttime wandering) in patients with dementia with Lewy bodies (DLB)?

1 Answer available

For patients with significant side effects to a cholinesterase inhibitor, do you try another medication in the class or avoid it altogether?

If you have significant side effects, GI and/or cardiac with one of the cholinesterase inhibitors, would you try using another medication or would you...

1 Answer available

Do you use pimavanserin to treat psychotic symptoms in Lewy body dementia?

1 Answer available

How do you approach the workup and management of patients with suspected functional neurologic disorders?

What testing do you typically proceed with?

1 Answer available